Muscarinic M1 receptor agonist
This page covers all Muscarinic M1 receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting M1 muscarinic acetylcholine receptor.
Targets
M1 muscarinic acetylcholine receptor
Phase 3 pipeline (1)
- ACP-204 · ACADIA Pharmaceuticals Inc. · Psychiatry / Neurology
ACP-204 is a muscarinic M1 receptor agonist that enhances cholinergic neurotransmission to improve cognitive and psychiatric symptoms.